RxDoctor Payments Data

Milena Jones, APRN

Nurse Practitioner · Aurora, ILNPI 1164979399

Payments from drug & device makers

$2,453in general payments, 2019–2025

Across 110 payments — averaging $22.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Boston Scientific$316
  • Amgen$179
  • Redhill Biopharma Inc.$113
  • Novo Nordisk$107
  • Pfizer$107
  • plus $499 from 11 others

What the payments were for

  • Food & beverage$2,453100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,453 in reported general payments places this provider in the 90th percentile of 4,869 nurse practitioner providers in Illinois.

See all nurse practitioner providers in Illinois

Medicare billing

Part B allowed, 2024
$33,059
Medicare patients
119
Services billed
458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
UbrelvyUbrogepant23$37,223
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen531$18,719
MovantikNaloxegol Oxalate31$12,587
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen116$5,185
Fentanyl44$3,662
Pregabalin134$2,429
Gabapentin141$1,938
Morphine Sulfate ErMorphine Sulfate53$1,416
Cyclobenzaprine Hcl74$936
Oxycodone Hcl44$900
Tizanidine Hcl95$689
Duloxetine Hcl26$332
Tramadol Hcl52$312
Topiramate15$90
Diazepam15$33

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieUbrelvy$1,132$37,22323 claims
Redhill Biopharma Inc.Movantik$113$12,58731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,869 nurse practitioner providers in Illinois.

Other nurse practitioner in Aurora

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →